Govind K Babu

486 total citations
13 papers, 105 citations indexed

About

Govind K Babu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Govind K Babu has authored 13 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Govind K Babu's work include Advanced Breast Cancer Therapies (3 papers), Hematological disorders and diagnostics (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Govind K Babu is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Hematological disorders and diagnostics (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Govind K Babu collaborates with scholars based in India, Spain and United States. Govind K Babu's co-authors include Linu Abraham Jacob, Young‐Hyuck Im, Yen‐Shen Lu, Aditya Bardia, Fábio Franke, Louis WC Chow, Debu Tripathy, Karen Rodriguez-Lorenc, David Chandiwana and Rafael Villanueva-Vázquez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and OncoTargets and Therapy.

In The Last Decade

Govind K Babu

12 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Govind K Babu India	6	63	62	23	14	14	13	105
Giuliana D’Auria Italy	8	119 1.9×	164 2.6×	21 0.9×	17 1.2×	7 0.5×	24	219
Hamadi Almotlak France	8	75 1.2×	78 1.3×	15 0.7×	16 1.1×	6 0.4×	19	134
Federico Augusto Sanchez United States	7	28 0.4×	69 1.1×	13 0.6×	11 0.8×	16 1.1×	15	127
Luke Mountjoy United States	7	28 0.4×	86 1.4×	14 0.6×	14 1.0×	32 2.3×	16	148
Montse Puigdemont Spain	7	28 0.4×	47 0.8×	11 0.5×	39 2.8×	11 0.8×	17	112
Timothy F. Goggins United States	7	21 0.3×	50 0.8×	11 0.5×	6 0.4×	21 1.5×	12	89
Julia Dudnik Israel	9	89 1.4×	86 1.4×	16 0.7×	6 0.4×	8 0.6×	23	143
H. Riess Germany	6	31 0.5×	87 1.4×	35 1.5×	8 0.6×	31 2.2×	11	150
Justin Shaya United States	8	92 1.5×	80 1.3×	47 2.0×	13 0.9×	11 0.8×	18	179
Yan-Song Liu China	4	28 0.4×	103 1.7×	37 1.6×	4 0.3×	6 0.4×	6	111

Countries citing papers authored by Govind K Babu

Since Specialization

Citations

This map shows the geographic impact of Govind K Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Govind K Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Govind K Babu more than expected).

Fields of papers citing papers by Govind K Babu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Govind K Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Govind K Babu. The network helps show where Govind K Babu may publish in the future.

Co-authorship network of co-authors of Govind K Babu

This figure shows the co-authorship network connecting the top 25 collaborators of Govind K Babu. A scholar is included among the top collaborators of Govind K Babu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Govind K Babu. Govind K Babu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Harbeck, Nadia, Fábio Franke, Rafael Villanueva-Vázquez, et al.. (2020). Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7). Therapeutic Advances in Medical Oncology. 12. 3863558105–3863558105. 33 indexed citations

Nanda, Ranjan Kumar, et al.. (2019). A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma. South Asian Journal of Cancer. 8(3). 178–182. 4 indexed citations

Jacob, Linu Abraham, K C Lakshmaiah, Govind K Babu, et al.. (2018). Clinicopathological Profile and Treatment Outcomes of Bilateral Breast Cancer: A Study from Tertiary Cancer Center in South India. Indian Journal of Medical and Paediatric Oncology. 39(1). 58–61. 2 indexed citations

Gupta, Sudeep, Govind K Babu, Raju Titus Chacko, et al.. (2018). An open label, single arm, prospective phase II study to evaluate the efficacy and safety of bevacizumab with gemcitabine and carboplatin as first-line treatment for metastatic triple negative breast cancer patients.. Journal of Clinical Oncology. 36(15_suppl). 1098–1098. 2 indexed citations

Babu, Govind K, et al.. (2017). Safety and antitumor activity of arsenic trioxide plus infusional 5-fluorouracil, leucovorin, and irinotecan as second-line chemotherapy for refractory metastatic colorectal cancer: A pilot study from South India. Indian Journal of Cancer. 54(4). 631–631. 3 indexed citations

Lakshmaiah, K C, Govind K Babu, D. Lokanatha, et al.. (2017). First-line tyrosine kinase inhibitors in metastatic renal cell carcinoma: A regional cancer center experience. Indian Journal of Cancer. 54(4). 626–626. 3 indexed citations

Babu, Govind K, et al.. (2017). Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India. Lung India. 34(2). 176–178. 5 indexed citations

Premalata, C S, et al.. (2016). Plasma Epstein–Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses. Indian Journal of Medical and Paediatric Oncology. 37(3). 146–151. 11 indexed citations

Lakshmaiah, K C, et al.. (2015). Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India. Hematology/Oncology and Stem Cell Therapy. 9(1). 8–13. 6 indexed citations

10.

Babu, Govind K, et al.. (2015). Hyperleukocytosis, an unusual paraneoplastic manifestation of lung cancer. Journal of Cancer Research and Therapeutics. 11(3). 669–669. 12 indexed citations

11.

Babu, Govind K, Ashok K. Vaid, Bhawna Sirohi, et al.. (2014). Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study. OncoTargets and Therapy. 7. 1051–1051. 22 indexed citations

12.

Babu, Govind K, et al.. (2013). A case of synchronous double malignancy: Invasive bladder cancer and Leiomyosarcoma of extremity and review of literature. SHILAP Revista de lepidopterología. 2(3). 152–152.

13.

Jacob, Linu Abraham, et al.. (2006). A retrospective study of clinico-hematological and cytogenetic profile of erythroleukemia from South India.. PubMed. 23(3). 158–63. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact